Table 4 Outcomes for different prophylaxis
|  | Overall (N = 884) | Mechanical prophylaxis group (N = 93) | Pharmacological prophylaxis group (N = 387) | Pharmacological combined mechanical prophylaxis group (N = 404) | P value |
|---|---|---|---|---|---|
VTE, n (%) | 126 (14.3) | 13 (14.0) | 47 (12.1) | 66 (16.3) | 0.240 |
PTE, n (%) | 1 (0.1) | 0 (0) | 1 (0.3) | 0 (0.0) | – |
DVT, n (%) | 125 (14.1) | 13 (14.0) | 46 (11.9) | 66 (16.3) | 0.201 |
Proximal DVT, n (%) | 18 (2.0) | 1 (1.1) | 6 (1.6) | 11 (2.7) | 0.452 |
Proximal DVT alone, n (%) | 9 (1.0) | 1 (1.1) | 3 (0.8) | 5 (1.2) | – |
Proximal and distal DVT, n (%) | 9 (1.0) | 0 (0) | 3 (0.8) | 6 (1.5) | – |
IDDVT, n (%) | 107 (12.1) | 12 (12.9) | 40 (10.3) | 55 (13.6) | 0.369 |
Bleeding events, n (%) | 143 (16.2) | 13 (14.0) | 67 (17.3) | 63 (15.6) | 0.683 |
Major bleeding events, n (%) | 83 (9.4) | 6 (6.5) | 38 (9.8) | 39 (9.7) | 0.596 |
Anticoagulant-related thrombocytopenia, n (%) | 5 (0.6) | 0 (0.0) | 4 (1.0) | 1 (0.2) | 0.331 |
Mortality during RICU hospitalization, n (%) | 256 (29.0) | 22 (23.7) | 124 (32.0) | 110 (27.2) | 0.167 |
LOS in RICU (days, IQR) | 12 (7, 20) | 10 (6, 15) | 10.0 (6, 19) | 14.0 (9, 25)* | < 0.001 |